Clinical Trial Update: Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control [Phase 3]

View source ↗

Summary

Phase 3 trial assessing sotagliflozin for glucose control in adults with type 2 diabetes and moderate kidney impairment (Chronic Kidney Disease Stage 3); study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3 | Phase 3 | Status: COMPLETED | Results posted: 2021-06-25